ASRS
RPRX icon

Arizona State Retirement System’s Royalty Pharma RPRX Stock Holding History

Arizona State Retirement System’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Buy
117,853
+7,565
+7% +$394K 0.03% 393
2026
Q1 		$5.29M Sell
110,288
-2,320
-2% -$102K 0.03% 407
2025
Q4 		$4.35M Buy
112,608
+528
+0.5% +$20.1K 0.02% 484
2025
Q3 		$3.95M Buy
112,080
+4,411
+4% +$160K 0.02% 522
2025
Q2 		$3.88M Sell
107,669
-1,528
-1% -$50.6K 0.02% 509
2025
Q1 		$3.4M Sell
109,197
-1,440
-1% -$45.6K 0.02% 531
2024
Q4 		$2.82M Buy
110,637
+537
+0.5% +$14.2K 0.02% 602
2024
Q3 		$3.11M Buy
110,100
+5,800
+6% +$161K 0.02% 576
2024
Q2 		$2.75M Sell
104,300
-132
-0.1% -$3.66K 0.02% 575
2024
Q1 		$3.17M Sell
104,432
-444
-0.4% -$13.1K 0.02% 542
2023
Q4 		$2.95M Buy
104,876
+940
+0.9% +$25.8K 0.02% 546
2023
Q3 		$2.82M Buy
103,936
+1,134
+1% +$33.7K 0.02% 528
2023
Q2 		$3.16M Buy
102,802
+209
+0.2% +$7.08K 0.03% 502
2023
Q1 		$3.7M Buy
102,593
+3,605
+4% +$134K 0.03% 466
2022
Q4 		$3.91M Buy
98,988
+3,369
+4% +$141K 0.04% 426
2022
Q3 		$3.84M Sell
95,619
-1,051
-1% -$44.9K 0.04% 398
2022
Q2 		$4.06M Buy
96,670
+1,024
+1% +$42K 0.04% 410
2022
Q1 		$3.73M Buy
95,646
+2,639
+3% +$104K 0.03% 498
2021
Q4 		$3.71M Buy
93,007
+43,394
+87% +$1.69M 0.03% 509
2021
Q3 		$1.79M Buy
49,613
+246
+0.5% +$9.56K 0.01% 768
2021
Q2 		$2.02M Sell
49,367
-992
-2% -$42.2K 0.02% 729
2021
Q1 		$2.2M Buy
50,359
+17,746
+54% +$841K 0.02% 682
2020
Q4 		$1.63M Buy
+32,613
New +$1.38M 0.01% 777

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's RPRX Position: Q2 2026 in Review

Arizona State Retirement System increased its Royalty Pharma (RPRX) stake by 6.9% in Q2 2026, buying an estimated $394K and bringing the position to 117,853 shares worth $6.61M. The position accounts for 0.03% of the portfolio, ranked #393.

Arizona State Retirement System first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Arizona State Retirement System held 117,853 shares of Royalty Pharma worth $6.61M as of Q2 2026.
  • Arizona State Retirement System bought 7,565 Royalty Pharma shares in Q2 2026, an estimated $394K.
  • Royalty Pharma made up 0.03% of Arizona State Retirement System's portfolio in Q2 2026, its #393 holding.
  • Arizona State Retirement System first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.